Category: Forex

October 12, 2023 BY Elizabeth Anderson

Success of Ozempic kidney failure trials proves disastrous for dialysis stocks

The company indicated the trial would come to an end, approximately a year before scheduled completion, following a recommendation from an independent data monitoring committee. Ozempic, a treatment commonly used for Type 2 Diabetes, contains semaglutide. The trial aimed to discover if it could stem the progress of kidney disease and help with associated complications. …

Read more
October 11, 2023 BY Elizabeth Anderson

IMAX China votes against privatisation transaction

Despite 70% of shareholders voting in favour of the $124m buyout, the votes against surpassed the 10% limit stipulated by Hong Kong Law to defeat a privatisation deal. Currently, the IMAX Corporation, which is parent to IMAX China, owns 71.6% of its subsidiary. It needed 75% of the votes to get the deal through.  In…

Read more
October 11, 2023 BY Elizabeth Anderson

GMHBA announces appointment of Michael Sammels to its board

The newly-appointed GMBHA board member previously held the position of chief financial officer at both Medibank Private and Healthscope. In this role, Sammels gained extensive knowledge and experience in private health insurance and hospital landscapes. Don’t miss out the latest news, subscribe to LeapRate’s newsletter The company believes his expertise in finance, accounting, capital developments, and…

Read more
October 10, 2023 BY Elizabeth Anderson

Impact of Israel-Hamas conflict on global stock movements

The global financial sphere kept a close eye on stocks to identify and track the specific geopolitical risks as relevant markets opened on Monday. Analysts predicted a rise in the buying of assets such as gold and US currency, followed by an increased demand for US Treasuries.  In line with these predictions, US stock futures…

Read more
October 06, 2023 BY Elizabeth Anderson

Exxon eyeing Pioneer in possible $60bn acquisition

Experts estimate that such an acquisition could be worth as much as $60bn.  They would be Exxon’s most significant endeavour since the $81bn merger with Mobil Corp. in To date, one of 2023’s biggest agreements were the Pfizer Inc. $43bn acquisition of Seagen Inc. The Wall Street Journal first reported the possibility of an Exxon…

Read more
Electronics
October 06, 2023 BY Elizabeth Anderson

BluGlass wins the position to become a member of the CLAWS Hub

This makes the company one of eight Microelectronics (ME) Commons regional innovation hubs announced by the US Department of Defence. As a CLAWS Hub member, BluGlass will develop next-generation photonics devices for commercial and strategic defence applications. Led by the North Carolina State University, this hub received $39.4 million in funding for the first year…

Read more